Healthcare / Medical Care FacilitiesHKSE
$11.77
-0.83 (-6.59%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 24% · confianza 25%
FCF escenarios
weak_data · normalized FCF $80.1M · quality 83.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
51/100
C
Piotroski
5/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$581M
P/E
15.9x
↓EV/EBITDA
3.0x
↓ROE
8.8%
↑Gross Margin
37.7%
↓Debt/Equity
0.23
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
-3.2%
FCF CAGR
-8.6%
FCF margin
21.6%
FCF / Net income
2.84x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $371.6M · net income $28.2M · FCF $80.1M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $371.6M | $371.6M | $407.1M | $441.8M | $409.4M |
| Net Income | $28.2M | $28.2M | $41.9M | $50.1M | $43.3M |
| EBITDA | $114.0M | $114.0M | $132.8M | $145.3M | $133.5M |
| EPS | 0.64 | 0.64 | 0.74 | 1.01 | 0.88 |
| Gross Margin | 37.7% | 37.7% | 37.4% | 38.1% | 36.3% |
| Operating Margin | 17.7% | 17.7% | 18.8% | 19.2% | 16.5% |
| Net Margin | 7.6% | 7.6% | 10.3% | 11.3% | 10.6% |
| Balance Sheet | |||||
| Debt/Equity | 0.23 | 0.23 | 0.98 | 0.77 | 0.96 |
| Current Ratio | 3.35 | 3.35 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $80.1M | $80.1M | $77.2M | $130.5M | $105.1M |
| Returns | |||||
| ROE | 8.8% | 8.8% | 36.2% | 38.1% | 37.3% |
| Valuation | |||||
| P/E | 15.91 | 15.91 | — | — | — |
| EV/EBITDA | 2.97 | 2.97 | — | — | — |
| P/B | 1.61 | 1.61 | — | — | — |
| Growth & Yield | |||||
| Revenue Growth | -8.7% | -8.7% | -7.9% | 7.9% | — |
| EPS Growth | -13.5% | -13.5% | -27.0% | 15.5% | — |
| Dividend Yield | 6.1% | 6.1% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
17.7%
EPS terminal req.
$1.04
Spread vs growth
-31.2%
5Y implied EPS CAGR
14.6%
EPS terminal req.
$1.26
Spread vs growth
-28.1%
10Y implied EPS CAGR
12.3%
EPS terminal req.
$2.04
Spread vs growth
-25.8%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-37.1%
Start / end P/E
28.0x → 18.4x
EPS bridge
0.74 → 0.64
Residual
+4.6%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.